FDA Scrutiny Scant In India, China as Drugs Pour Into U.S. - Broad Overseas Checks Called Too Costly - Washington Post

Excerpt:
"India and China, countries where the Food and Drug Administration rarely conducts quality-control inspections, have become major suppliers of low-cost drugs and drug ingredients to American consumers. Analysts say their products are becoming pervasive in the generic and over-the-counter marketplace.

Over the past seven years, amid explosive growth in imports from India and China, the FDA conducted only about 200 inspections of plants in those countries, and a few were the kind that U.S. firms face regularly to ensure that the drugs they make are of high quality."

Read Story

Sphere: Related Content